Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol. 2017 12 15; 313:77-81.
View in:
PubMed
subject areas
Animals
Animals
Anti-Inflammatory Agents
Anti-Inflammatory Agents
Apoptosis
Apoptosis
CD11b Antigen
CD11b Antigen
Cell Death
Cell Death
Cell Proliferation
Cell Proliferation
Cytokines
Cytokines
Disease Models, Animal
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental
Encephalomyelitis, Autoimmune, Experimental
fas Receptor
fas Receptor
Female
Female
Fluoxetine
Fluoxetine
Freund's Adjuvant
Freund's Adjuvant
Macrophages
Macrophages
Membrane Potential, Mitochondrial
Membrane Potential, Mitochondrial
Mice
Mice
Mice, Transgenic
Mice, Transgenic
Myelin Basic Protein
Myelin Basic Protein
Myelin Proteolipid Protein
Myelin Proteolipid Protein
Peptide Fragments
Peptide Fragments
Receptors, Antigen, T-Cell
Receptors, Antigen, T-Cell
T-Lymphocytes
T-Lymphocytes
authors with profiles
Robert Axtell